arrow
R

Roger Bedimo

open forum infectious diseases
H指数:33
被引数:5,392

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Duty to Act

行动的义务

2026-09-010
PRE
A Duty to Act

行动的义务

2026-09-010
OAAI
A Duty to Act

行动的义务

2026-09-010
OAAI
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

2025年美国传染病学会关于COVID-19治疗和管理临床实践指南更新:Pemivibart用于暴露前预防,Vilobelimab用于危重疾病,Abatacept或Infliximab用于严重或危重疾病

2025-10-010
OAAI
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept

2025年美国传染病学会关于COVID-19治疗和管理的临床实践指南更新:Abatacept

2025-09-010
OAAI
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab

2025年美国传染病学会关于COVID-19治疗与管理的临床实践指南更新:Infliximab

2025-08-011
OAAI
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab

2025年美国传染病学会关于COVID-19治疗与管理的临床实践指南更新:Vilobelimab

2025-07-011
OAAI
Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With Human Immunodeficiency Virus (HIV)

影响人类免疫缺陷病毒(HIV)感染者全球心血管疾病(CVD)预防队列中心血管事件风险的因素

2025-04-250
PRE
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort
2025-04-010
OAAI
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel
2025-02-181
PRE
Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study

人类免疫缺陷病毒患者中SARS-CoV-2感染的危险因素和严重结局: 队列研究

2023-07-246
OAAI
Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient Veterans

住院退伍军人多站点前瞻性队列中SARS-CoV-2感染的早期结果

2023-06-271
OA